Research/News - 2022

Mindfulness Intervention for Pregnant and Parenting WLWH

Dec 28, 2022

The authors describe their experience conducting focus groups to inform the adaptation of a mindfulness intervention for pregnant and parenting women living with HIV. They detail the focus group experience exploring psychosocial treatment needs and mindfulness... Read More

Importance of Timely Diagnosis of Perinatal HIV in Children

Dec 28, 2022

The authors present the case of a 6-year-old child with a delayed diagnosis of perinatal HIV infection. They describe the increased morbidity resulting from the delay and remind clinicians of the importance of universal HIV screening of pregnant women (including repeat... Read More

Disparities in Third Trimester Syphilis Testing in Illinois

Sep 20, 2022

The authors, including Hotline Co-Medical Director Dr. Lynn Yee, report on their findings regarding repeat third trimester syphilis testing at a large tertiary hospital in Chicago, Illinois. They observe overall low compliance with the state law mandating repeat third... Read More

New Findings on the Use of Dolutegravir in Pregnancy

Sep 20, 2022

A recent comparative study in the New England Journal of Medicine reports on the benefits of Dolutegravir in pregnancy compared to other HIV regimens currently used in the United States. Patel K, Huo Y, Jao J, et al. Dolutegravir in pregnancy as compared with current... Read More

Change in Reporting Requirements Announced by IDPH

Sep 16, 2022

The Illinois Department of Public Health (IDPH) has announced a change in reporting requirements for Perinatal HIV Rapid Testing Monthly Reports. As of July 1, 2022, reports are to be sent to Mother and Child Alliance (MACA), previously known as Pediatric AIDS Chicago... Read More

Updated Hotline Guidelines for Infants with Perinatal HIV Exposure

May 16, 2022

The 24/7 Illinois Perinatal HIV Hotline has released updated Best Practices for the Care of Infants with Perinatal Exposure to HIV. Main updates include: Modified criteria for determination of infant risk status NVP dosing for ≥32 to <34 weeks’ gestation... Read More

Updated Guidance for COVID-19 and People Living with HIV

Feb 25, 2022

The Guidelines Working Groups of the NIH Office of AIDS Research Advisory Council have released a summary of updates made to their Guidance for COVID-19 and People with HIV since the last publication of this guidance in February 2021. It includes updated recommendations... Read More

Update to COVID-19 Treatment Guidelines for People Living with HIV

Feb 08, 2022

The COVID-19 Treatment Guidelines Panel (the Panel) has published a revised version of the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Key changes specific to people with HIV include: The Panel notes that people with advanced or untreated HIV who do... Read More

Updated Perinatal Guidelines Released

Jan 06, 2022

The HHS Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission recently updated several sections of the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United... Read More